Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-002145-21-BE
EUCTR2007-002145-21-BE
Active, not recruiting
Not Applicable

A Phase II, Randomized, Placebo-controlled Study of ATI-7505 in Patients with Chronic Idiopathic Constipation

Procter & Gamble Pharmaceuticals0 sitesOctober 3, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Idiopathic ConstipationMedDRA version: 9.1Level: LLTClassification code 10063582Term: Constipation chronic

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Idiopathic Constipation
Sponsor
Procter & Gamble Pharmaceuticals
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 3, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Procter & Gamble Pharmaceuticals

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
A Phase II, Randomized, Placebo-controlled Study of ATI-7505 in Patients with Chronic Idiopathic Constipatio
EUCTR2007-002145-21-GBProcter & Gamble Pharmaceuticals400
Active, not recruiting
Not Applicable
A Phase II, Randomized, Placebo-controlled Study of ATI-7505 in Patients with Chronic Idiopathic Constipatio
EUCTR2007-002145-21-DEProcter & Gamble Pharmaceuticals400
Active, not recruiting
Phase 1
A Phase 2 study to evaluate safety and efficacy of Evinacumab in patients with severe hypertriglyceridemia at risk for acute pancreatitis.Severe Hypertriglyceridemia (sHTG)MedDRA version: 20.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2016-003307-62-GBRegeneron Pharmaceuticals, Inc.50
Active, not recruiting
Phase 2
Effect of Baricitinib on Insulin Production in Type 1 DiabetesType 1 Diabetes MellitusMetabolic and Endocrine - Diabetes
ACTRN12620000239965St Vincent’s Institute of Medical Research91
Active, not recruiting
Phase 1
A clinical trial to test a new vaccine, in avoiding cytomegalovirus (CMV) infection after transplant, if you have never encountered the virus and your donor may harbor it.
EUCTR2017-005047-32-ATHookipa Biotech GmbH150